denali therapeutics stock news
The firm has a market cap of 283 billion a PE ratio of -982 and a beta of 190. Denali Therapeutics NASDAQDNLI - Get Rating last posted its quarterly earnings.
Denali Therapeutics On The Move
DNLI stock quote history news and other vital information to help you with your stock trading and investing.
. The company has a 50-day simple moving average of 2991 and a 200-day simple moving average of 3768. In trading on Wednesday shares of Denali Therapeutics Inc Symbol. Denali Therapeutics Inc.
Get Denali Therapeutics Inc DNLINASDAQ real-time stock quotes news price and financial information from CNBC. DNLI stock at Seeking Alpha. DNLI entered into oversold territory hitting an RSI reading of 273 after.
DNLI fell 383 Wednesday. DNLI May Report Negative Earnings. View analysts price targets for Denali Therapeutics or view top-rated stocks among Wall Street analysts.
16 hours agoDenali Therapeutics has a 1 year low of 2175 and a 1 year high of 7970. This suggests a possible upside of 2720 from the stocks current price. Get the latest news and real-time alerts from Denali Therapeutics Inc.
At the close of trading the stocks price was 3045 to imply a decrease of -187 or -058 in intraday trading. 11 hours agoIn other Denali Therapeutics news CFO Steve E. As of 115330 est Denali sits at 2236 and has fallen 088 per share.
Find the latest Denali Therapeutics Inc. An evaluation of the daily trading volume of Denali Therapeutics Inc. 4 months ago - Zacks Investment Research.
Know the Trend Ahead of Q1 Release. Shares of Denali Therapeutics Inc NASDAQ. Do the numbers hold clues to what lies ahead for the.
DNLI delivered earnings and revenue surprises of -3529 and -7845 respectively for the quarter ended September 2021. Stock Market News - Financial News - MarketWatch. Get the latest Denali Therapeutics stock price and detailed information including DNLI news historical charts and realtime prices.
This is the News-site for the company Denali Therapeutics on Markets Insider. The company has a 50 day simple moving average of 2991 and a 200 day simple moving average of 3768. 11 hours agoDenali Therapeutics stock opened at 2298 on Wednesday.
The DNLI shares 52-week high remains 7970 putting it -16174 down since. NASDAQDNLI indicates that the 3-month average is 50870K. However since the stocks price has.
Shares of Denali Therapeutics DNLI -495 had sunk 112 as of 1202 pm. NASDAQDNLIs traded shares stood at 061 million during the last session with the companys beta value hitting 181. Get the latest Denali Therapeutics Inc.
Krognes sold 2560 shares of Denali Therapeutics stock in a transaction dated Friday February 11th. Our core portfolio currently consists of. On average they expect Denali Therapeutics stock price to reach 8575 in the next year.
The shares were sold at an average price of 34. Common Stock DNLI Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Real time Denali Therapeutics Inc DNLI stock price quote stock graph news analysis.
Their forecasts range from 4800 to 11100. The decline came after the company presented interim results on Sunday from a phase 12 study evaluating. The insiders hold 210 of outstanding shares whereas institutions hold 7930.
The firm has a market. The programs in our portfolio are based on our deep expertise in the biology of neurodegenerative diseases and the blood-brain barrier. Currently records show that 12267 million of the companys shares remain outstanding.
DNLI stock news and headlines to help you in your trading and investing decisions. Denali Therapeutics Inc. Denali Therapeutics stock price target cut to 41 from 60 at Stifel Nicolaus.
Denali Therapeutics Inc. Biogen reports 1116 passive stake in Denali. A high-level overview of Denali Therapeutics Inc.
Denali is applying deep scientific and drug development expertise to fully harvest the potential of these pathways in order to discover effective molecular therapeutics. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.
Denali Therapeutics Inc Dnli Moves 7 5 Higher Will This Strength Last
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
26 10 Million In Sales Expected For Denali Therapeutics Inc Nasdaq Dnli This Quarter Defense World
Denali Therapeutics 2021 Was Mostly Bad Luck And Trouble Nasdaq Dnli Seeking Alpha
Denali Therapeutics Price Target Analyst Ratings Nasdaq Dnli
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
Bearish Analysts Just Cut Their Denali Therapeutics Inc Nasdaq Dnli Revenue And Eps Estimates
Denali Sec Filings
Dnli Stock Crashes Why Investors Are Questioning The Viability Of Its Pipeline Investor S Business Daily
26 10 Million In Sales Expected For Denali Therapeutics Inc Nasdaq Dnli This Quarter Defense World
Denali Therapeutics High Resolution Stock Photography And Images Alamy
Denali Therapeutics Inc Analytics Traffic Statistics And Competitor Tracking Watchmycompetitor
Why Denali Therapeutics Stock Is Sinking Today The Motley Fool
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
Denali Therapeutics Key Catalysts Coming Up For This Neurodegenerative Disease Pioneer Nasdaq Dnli Seeking Alpha
Dnli Institutional Ownership Denali Therapeutics Inc Nasdaq Stock
Denali Therapeutics Inc S Nasdaq Dnli Stock Has Shown Weakness Lately But Financial Prospects Look Decent Is The Market Wrong
Denali Is Flush With Cash After Partnership With Biogen Nasdaq Dnli Seeking Alpha
Why Denali Therapeutics Stock Is Sinking Today The Motley Fool